Brazil judge suspends drug patent extensions, move may lower COVID-19 treatment costs

In the case, federal prosecutors asked the Supreme Court to reconsider parts of Brazil's Industrial Property Law, saying it protects patents for an "excessive time period," harming "social interest." The lawsuit was launched in 2016, and the country's top prosecutor, Augusto Aras, asked the Supreme Court in February for an urgent ruling, arguing for the need to allow more generic drugs to treat COVID-19.

Reuters | Updated: 08-04-2021 05:55 IST | Created: 08-04-2021 05:55 IST
Brazil judge suspends drug patent extensions, move may lower COVID-19 treatment costs

A Brazilian Supreme Court judge on Wednesday suspended extensions of drug patents in the country, a preliminary decision that could lower costs for drugs critical to treating COVID-19 patients at the expense of pharmaceutical firms. Justice Dias Toffoli cited the "public health emergency arising from COVID-19" in his ruling. The ruling, which takes effect immediately, must still go before the full Supreme Court for consideration and could be reversed.

The case was originally set to be considered by the court on Wednesday but was later pulled from the agenda for proceedings. In the case, federal prosecutors asked the Supreme Court to reconsider parts of Brazil's Industrial Property Law, saying it protects patents for an "excessive time period," harming "social interest."

The lawsuit was launched in 2016, and the country's top prosecutor, Augusto Aras, asked the Supreme Court in February for an urgent ruling, arguing for the need to allow more generic drugs to treat COVID-19. "When patents are still in effect, it is impossible to produce generics to treat the coronavirus and its variants," said the filing by Aras.

Companies defending the current law say the extended lifetime of a patent is important to compensate companies for their investments in research and development of new drugs, pesticides and other controlled substances. Brazilian law protects drug patents for 20 years, allowing a renewal for another 10 years. The period is counted from the date of a patent application, rather than when it is granted. Drugmakers argue that long wait times for approval make the extensions necessary to justify their investments.

The Affordable Medicines Movement, which lobbies for lower drug prices, says extension of patents contributes to higher prices and less availability of drugs. The group said scrapping the extensions would lower costs for a drug used when intubating patients and a type of blood thinner used for treating COVID-19.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

Death toll in Gaza soars to 188 as Israel-Palestine conflict continues

The death toll in Palestine due to Israeli airstrikes has reached 188 as the conflict entered its seventh day on Sunday. Among those killed were 55 children, the the Gaza Health Ministry said. Another 1,230 Palestinians were wounded in the ...

U.N. chief says Israel, Gaza fighting 'utterly appalling'

U.N. Secretary-General Antonio Guterres told the U.N. Security Council on Sunday that hostilities in Israel and Gaza were utterly appalling and called for an immediate end to fighting.He said the United Nations is actively engaging all side...

Harry has been our leader, hopefully he'll be ready for Europa final: Solskjaer

Manchester United manager Ole Gunnar Solskjaer has said that he is hopeful of Harry Maguires return for the finals of the Europa League. United still have two league games left of the campaign in the Premier League against Fulham and Wolver...

COVID-19: UP reports 311 more deaths, 10,682 fresh cases

The COVID-19 death toll in Uttar Pradesh rose to 17,546 with 311 more fatalities while the infection tally climbed to 16,19,645 as 10,682 fresh coronavirus cases were reported, officials said on Sunday.Of the fresh deaths, Meerut reported 2...

Give Feedback